OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder-Reference-Cited by-同舟云学术

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder

Published:2014-04-22 Issue:10 Volume:68 Page:1246-1256
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Sievert K.‐D.¹,Chapple C.²,Herschorn S.³,Joshi M.⁴,Zhou J.⁵,Nardo C.⁴,Nitti V. W.⁶

Affiliation:

1. Department of Urology University of Tuebingen Tuebingen Germany

2. Department of Urology Royal Hallamshire Hospital Sheffield UK

3. Department of Urology University of Toronto Toronto ON Canada

4. Allergan, Inc. Irvine CA USA

5. Allergan, Inc. Bridgewater NJ USA

6. Department of Urology and Obstetrics and Gynecology New York University Langone Medical Center New York NY USA

Funder

Allergan

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.12443

Reference30 articles.

1. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

2. Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study

3. Prevalence and Co-Occurrence of Pelvic Floor Disorders in Community-Dwelling Women

4. Reviewing the ICS 2002 terminology report: The ongoing debate

5. Impact of Urinary Incontinence and Overactive Bladder on Quality of Life

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies;Toxins;2024-08-05

2. Title：Cross-sectional Examination of the Association Between Life's Essential 8 Score and Overactive Bladder——NHANES 2005-2018;2024-03-29

3. Long term safety outcomes and continuation rates of repeated Intravesical Botulinum Toxin A injections for Detrusor Overactivity: 16 year’s experience of a Tertiary Centre in the UK;Continence;2024-03

4. Harninkontinenz bei Frauen operieren?;Uro-News;2024-01

5. Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment;Toxins;2023-12-21